Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Insulin Aspart in Type 1 Diabetes Extension
NCT00832182Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Dec 1999
- Primary completion
- Nov 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of insulin aspart in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Dec 1999; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00832182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832182.